EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access · CC BY-NC-ND 4.0

MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up

Hannah Thurgur iD, Ben Sessa, Laurie Higbed, Steve O'Brien, Claire Durant, Sue Wilson, Balázs Szigeti, Celia J A Morgan, David J Nutt

Alcohol and Alcoholism · 14.05.2025 · 60 (4)

DOI: 10.1093/alcalc/agaf031 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Alcohol and Alcoholism, online erschienen am 09.06.2025. Verfasst von Hannah Thurgur und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Psychiatry, Department of Brain Sciences, Imperial College London, The Commonwealth Building, Du Cane Road, London, W12 0NN, United Kingd…. Hauptthemen laut MEDLINE: Alcohol Drinking, Alcoholism, N-Methyl-3,4-methylenedioxyamphetamine, Psychosocial Functioning. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Safety and tolerability data from the first open-label feasibility study of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for alcohol use disorder was recently published. This paper presents a Bayesian analysis of the impact of MDMA-assisted psychotherapy on treatment success, defined as 2-level reduction in the World Health Organization (WHO) drinking risk at the 3 months follow-up. We also examined the impact on drinking behavior and psychosocial measures at 3 months compared to baseline.

Methods

Fourteen participants with a diagnosis of alcohol use disorder who had recently undergone detoxification completed an eight-week course of ten psychotherapy sessions, including two sessions with MDMA. Measures assessing drinking behavior, quality of life, sleep, self-compassion, and empathy were collected. Bayesian analysis using flat and skeptical priors was performed to determine treatment success defined as a 2-level reduction in WHO drinking risk.

Results

Bayesian analysis suggested that the probability of a 2-level reduction in WHO drinking risk from baseline to 3 months post-treatment is 55%–63%, based upon either a flat or skeptical prior respectively. We present preliminary findings suggesting reductions in alcohol craving (measured by the Penn Alcohol Craving Scale and Obsessive Compulsive Drinking Scale) and improvements in sleep and aspects of psychosocial functioning at 3 months follow-up compared to baseline.

Conclusions

The Bayesian analysis provides a useful harm reduction endpoint interpretation of drinking in terms of a 2-level reduction in WHO drinking risk. Further findings provide preliminary insights into the potential impact of MDMA-assisted psychotherapy on quality of life and well-being in addition to reductions in drinking. ClinicalTrials.gov ID: NCT04158778.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alcohol DrinkingAlcoholismN-Methyl-3,4-methylenedioxyamphetaminePsychosocial FunctioningPsychotherapyAdultFemaleHumansMaleMiddle AgedBayes TheoremFollow-Up StudiesQuality of LifeTreatment Outcome

Stichwörter der Autor:innen

MDMAcravingpsychosocialpsychotherapysleepwell-being

Substanzen

N-Methyl-3,4-methylenedioxyamphetamine

Autor:innen und Institutionen

  • Division of Psychiatry, Department of Brain Sciences, Imperial College London, The Commonwealth Building, Du Cane Road, London, W12 0NN, United Kingdom.
  • Independent Consultant.
  • Department of Psychiatry and Behavioural Sciences, University of California, 675 18th St, San Francisco, CA 94107, United States.
  • Psychopharmacology and Addiction Research Centre, University of Exeter, Stocker Road, EX4 4PY, United Kingdom.

ORCID-Profile: Hannah Thurgur

Zitieren

APA

Thurgur, H., Sessa, B., Higbed, L., O'Brien, S., Durant, C., Wilson, S., Szigeti, B., Morgan, C. J. A., & Nutt, D. J. (2025). MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up. Alcohol and Alcoholism, 60(4). https://doi.org/10.1093/alcalc/agaf031

Vancouver

Thurgur H, Sessa B, Higbed L, O'Brien S, Durant C, Wilson S, et al. MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up. Alcohol and Alcoholism. 2025;60(4). doi:10.1093/alcalc/agaf031

BibTeX
@article{Thurgur2025,
  author = {Thurgur, Hannah and Sessa, Ben and Higbed, Laurie and O'Brien, Steve and Durant, Claire and Wilson, Sue and Szigeti, Balázs and Morgan, Celia J A and Nutt, David J},
  title = {MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up},
  journal = {Alcohol and Alcoholism},
  year = {2025},
  volume = {60},
  number = {4},
  doi = {10.1093/alcalc/agaf031}
}
Kostenlos starten →